Brought to you by 
AngioScore brings in $30mm through its Series E round
25 Sep 2020
Executive Summary
AngioScore (angioplasty catheters) has raised $30mm through the closing of its Series E venture round. Telegraph Hill Partners led the financing and was joined by all of the company's current institutional investors including Psilos Group Managers, QuestMark Partners, UV Partners, California Technology Ventures, and InnoMed Ventures. Thomas Weisel was the placement agent.
Deal Industry
- Medical Devices
-
Medical Devices
-
Surgical Equipment & Devices
- Minimally or Less Invasive
-
Surgical Equipment & Devices
Deal Status
- Final
Deal Type
-
Financing
- Venture Financing
Already a Biomedtracker subscriber?
You have access to the full deal record through your subscription
Want to become a subscriber?
Subscribers get more deal details, updates, deal financials and deal products.
Questions?
Questions?
Please contact Sales at: (212) 520-2765 or email [email protected]
Related Companies
You must sign in to use this functionality
Authentication.SignIn.HeadSignInHeader
AngioScore brings in $30mm through its Series E round
Email Deal
All set! This article has been sent to my@email.address.
All fields are required. For multiple recipients, separate email addresses with a semicolon.
DCD.EmailPopout.Notice